JPRN-UMIN000000573已完成1 期
Phase I/II study of arterial infusion of 5-fluorouracil combined with systemic gemcitabine for unresectable pancreatic cancer - HAI-5-FU combined with GEM for unresectable pancreatic cancer
ara Medical University0 个研究点目标入组 24 人开始时间: 2007年1月16日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)distant metastaes except of liver and node 2)adequate drug distribution via celiac arterial infusion with alteration of pancreatic blood flow will not be achieved 3)Interstitial pneumonia in chest X-ray 4)active gastro-duodenal ulcer 5)Allergic reaction to iodine contrast material. 6)Infectious disease with fever over 38 degree Celcius or antibiotics required. 7)Pregnant or nursing. 8)Severe drug allergic reaction 9)The other severe complicated disease
研究者
相似试验
进行中（未招募）
不适用
Phase I/II study of continous infusion with 5-FU and weekly Oxaliplatin / Cetuximab combined with concurrent radiation as neoadjuvant treatment in locally advanced oesophageal squamous cell carcinoma.EUCTR2006-001097-24-DETechnische Universitaet Muenchen, Medizinische Fakultaet
已完成
不适用
Pharmacokinetic study of continuous-infusional 5-FU for esophageal carcinomaEsophageal carcinomaJPRN-UMIN000036566Keio University, School of Medicine50
已完成
2 期
pilot study of intraarterial 5-fluorouracil/interferon combination therapy for advanced hepatocellular carcinoma patients who do not response to intraarterial 5-fluorouracil/cisplatin combination therapy.advanced hepatocellular caricinomaJPRN-UMIN000002928Department of Medicine and Molecular Science, Division of Frontier Medical Science, Programs for Biomedical Research, Graduate School of Biomedical, Hiroshima University20
已完成
不适用
A Randomised Study of continuous infusion 5-Fluorouracil (5FU) with or without bolus Mitomycin-C in Patients with Advanced Pancreatic CancerPancreatic cancerMalignant neoplasm of pancreasCancerISRCTN61961630The Royal Marsden NHS Foundation Trust (UK)208
已完成
3 期
Adjuvant treatment with 5-fluorouracil and folinic acid with or without irinotecan in patients with Dukes B2 or C colon cancer.colon cancerCancer - Bowel - Back passage (rectum) or large bowel (colon)ACTRN12610000148077Hellenic Cooperative Oncology Group870